Delek Group’s Aravive, Inc. Common Stock ARAV Stock Holding History

Delek Group’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,987	Closed	-$145K	–	316
2017 Q4	$145K	Buy	+10,987	New	+$141K	0.01%	240

Other funds holding ARAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Delek Group's ARAV Position: Q1 2018 in Review

Delek Group sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2018, closing a stake of 10,987 shares — an estimated $145K sold.

Delek Group first reported a position in ARAV in Q4 2017 and held it in 1 quarter. The position peaked at $145K in Q4 2017. 69 funds tracked by Wall St. Rank hold ARAV as of Q1 2018.

Delek Group reported no remaining Aravive, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Delek Group sold 10,987 Aravive, Inc. Common Stock shares in Q1 2018, an estimated $145K.
Delek Group first reported a position in Aravive, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
Delek Group's Aravive, Inc. Common Stock position peaked at $145K in Q4 2017.
69 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2018.

Based on Delek Group's 13F filing for Q1 2018, filed 15 May 2018.